1 Report Overview

• 1.1 Study Scope
• 1.2 Market Analysis by Type
  • 1.2.1 Global Monoclonal Antibody Therapeutics Market Size Growth Rate by Type: 2020 VS 2026
  • 1.2.2 Humanized Antibody
  • 1.2.3 Human Mouse Chimeric Antibody
• 1.3 Market by Application
  • 1.3.1 Global Monoclonal Antibody Therapeutics Market Share by Application: 2020 VS 2026
  • 1.3.2 Cancer
  • 1.3.3 Autoimmune Diseases
  • 1.3.4 Infection
  • 1.3.5 Hematological Diseases
  • 1.3.6 Ophthalmological Diseases
  • 1.3.7 Others
• 1.4 Study Objectives
• 1.5 Years Considered

2 Global Growth Trends

• 2.1 Global Monoclonal Antibody Therapeutics Market Perspective (2015-2026)
• 2.2 Global Monoclonal Antibody Therapeutics Growth Trends by Regions
  • 2.2.1 Monoclonal Antibody Therapeutics Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 Monoclonal Antibody Therapeutics Historic Market Share by Regions (2015-2020)
  • 2.2.3 Monoclonal Antibody Therapeutics Forecasted Market Size by Regions (2021-2026)
• 2.3 Industry Trends and Growth Strategy
  • 2.3.1 Market Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Market Restraints

3 Competition Landscape by Key Players

• 3.1 Global Top Monoclonal Antibody Therapeutics Players by Market Size
  • 3.1.1 Global Top Monoclonal Antibody Therapeutics Players by Revenue (2015-2020)
  • 3.1.2 Global Monoclonal Antibody Therapeutics Revenue Market Share by Players (2015-2020)
• 3.2 Global Monoclonal Antibody Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.3 Players Covered: Ranking by Monoclonal Antibody Therapeutics Revenue
• 3.4 Global Monoclonal Antibody Therapeutics Market Concentration Ratio
  • 3.4.1 Global Monoclonal Antibody Therapeutics Market Concentration Ratio (CR5 and HHI)
  • 3.4.2 Global Top 10 and Top 5 Companies by Monoclonal Antibody Therapeutics Revenue in 2019
• 3.5 Key Players Monoclonal Antibody Therapeutics Area Served
• 3.6 Key Players Monoclonal Antibody Therapeutics Product Solution and Service
• 3.7 Date of Enter into Monoclonal Antibody Therapeutics Market
• 3.8 Mergers & Acquisitions, Expansion Plans

4 Monoclonal Antibody Therapeutics Breakdown Data by Type (2015-2026)

• 4.1 Global Monoclonal Antibody Therapeutics Historic Market Size by Type (2015-2020)
• 4.2 Global Monoclonal Antibody Therapeutics Forecasted Market Size by Type (2021-2026)

5 Monoclonal Antibody Therapeutics Breakdown Data by Application (2015-2026)

• 5.1 Global Monoclonal Antibody Therapeutics Historic Market Size by Application (2015-2020)
• 5.2 Global Monoclonal Antibody Therapeutics Forecasted Market Size by Application (2021-2026)

6 North America

• 6.1 North America Monoclonal Antibody Therapeutics Market Size (2015-2026)
• 6.2 North America Monoclonal Antibody Therapeutics Market Size by Type (2015-2020)
• 6.3 North America Monoclonal Antibody Therapeutics Market Size by Application (2015-2020)
• 6.4 North America Monoclonal Antibody Therapeutics Market Size by Country (2015-2020)
  • 6.4.1 United States
  • 6.4.2 Canada

7 Europe

• 7.1 Europe Monoclonal Antibody Therapeutics Market Size (2015-2026)
• 7.2 Europe Monoclonal Antibody Therapeutics Market Size by Type (2015-2020)
• 7.3 Europe Monoclonal Antibody Therapeutics Market Size by Application (2015-2020)
• 7.4 Europe Monoclonal Antibody Therapeutics Market Size by Country (2015-2020)
  • 7.4.1 Germany
  • 7.4.2 France
  • 7.4.3 U.K.
  • 7.4.4 Italy
  • 7.4.5 Russia
  • 7.4.6 Nordic
  • 7.4.7 Rest of Europe

8 China

• 8.1 China Monoclonal Antibody Therapeutics Market Size (2015-2026)
• 8.2 China Monoclonal Antibody Therapeutics Market Size by Type (2015-2020)
• 8.3 China Monoclonal Antibody Therapeutics Market Size by Application (2015-2020)
• 8.4 China Monoclonal Antibody Therapeutics Market Size by Region (2015-2020)
  • 8.4.1 China
  • 8.4.2 Japan
  • 8.4.3 South Korea
  • 8.4.4 Southeast Asia
  • 8.4.5 India
  • 8.4.6 Australia
  • 8.4.7 Rest of Asia-Pacific

9 Japan

• 9.1 Japan Monoclonal Antibody Therapeutics Market Size (2015-2026)
• 9.2 Japan Monoclonal Antibody Therapeutics Market Size by Type (2015-2020)
• 9.3 Japan Monoclonal Antibody Therapeutics Market Size by Application (2015-2020)
• 9.4 Japan Monoclonal Antibody Therapeutics Market Size by Country (2015-2020)
  • 9.4.1 Mexico
  • 9.4.2 Brazil

10 Southeast Asia

• 10.1 Southeast Asia Monoclonal Antibody Therapeutics Market Size (2015-2026)
• 10.2 Southeast Asia Monoclonal Antibody Therapeutics Market Size by Type (2015-2020)
• 10.3 Southeast Asia Monoclonal Antibody Therapeutics Market Size by Application (2015-2020)
• 10.4 Southeast Asia Monoclonal Antibody Therapeutics Market Size by Country (2015-2020)
  • 10.4.1 Turkey
  • 10.4.2 Saudi Arabia
  • 10.4.3 UAE
  • 10.4.4 Rest of Middle East & Africa

11 Key Players Profiles

• 11.1 Bayer
  • 11.1.1 Bayer Company Details
  • 11.1.2 Bayer Business Overview
  • 11.1.3 Bayer Monoclonal Antibody Therapeutics Introduction
  • 11.1.4 Bayer Revenue in Monoclonal Antibody Therapeutics Business (2015-2020))
  • 11.1.5 Bayer Recent Development
• 11.2 F. Hoffmann-La Roche
  • 11.2.1 F. Hoffmann-La Roche Company Details
  • 11.2.2 F. Hoffmann-La Roche Business Overview
  • 11.2.3 F. Hoffmann-La Roche Monoclonal Antibody Therapeutics Introduction
  • 11.2.4 F. Hoffmann-La Roche Revenue in Monoclonal Antibody Therapeutics Business (2015-2020)
  • 11.2.5 F. Hoffmann-La Roche Recent Development
• 11.3 Pfizer
  • 11.3.1 Pfizer Company Details
  • 11.3.2 Pfizer Business Overview
  • 11.3.3 Pfizer Monoclonal Antibody Therapeutics Introduction
  • 11.3.4 Pfizer Revenue in Monoclonal Antibody Therapeutics Business (2015-2020)
  • 11.3.5 Pfizer Recent Development
• 11.4 Sanofi
  • 11.4.1 Sanofi Company Details
  • 11.4.2 Sanofi Business Overview
  • 11.4.3 Sanofi Monoclonal Antibody Therapeutics Introduction
  • 11.4.4 Sanofi Revenue in Monoclonal Antibody Therapeutics Business (2015-2020)
  • 11.4.5 Sanofi Recent Development
• 11.5 GlaxoSmithKline
  • 11.5.1 GlaxoSmithKline Company Details
  • 11.5.2 GlaxoSmithKline Business Overview
  • 11.5.3 GlaxoSmithKline Monoclonal Antibody Therapeutics Introduction
  • 11.5.4 GlaxoSmithKline Revenue in Monoclonal Antibody Therapeutics Business (2015-2020)
  • 11.5.5 GlaxoSmithKline Recent Development
• 11.6 Merck
  • 11.6.1 Merck Company Details
  • 11.6.2 Merck Business Overview
  • 11.6.3 Merck Monoclonal Antibody Therapeutics Introduction
  • 11.6.4 Merck Revenue in Monoclonal Antibody Therapeutics Business (2015-2020)
  • 11.6.5 Merck Recent Development
• 11.7 Novartis
  • 11.7.1 Novartis Company Details
  • 11.7.2 Novartis Business Overview
  • 11.7.3 Novartis Monoclonal Antibody Therapeutics Introduction
  • 11.7.4 Novartis Revenue in Monoclonal Antibody Therapeutics Business (2015-2020)
  • 11.7.5 Novartis Recent Development
• 11.8 AbbVie
  • 11.8.1 AbbVie Company Details
  • 11.8.2 AbbVie Business Overview
  • 11.8.3 AbbVie Monoclonal Antibody Therapeutics Introduction
  • 11.8.4 AbbVie Revenue in Monoclonal Antibody Therapeutics Business (2015-2020)
  • 11.8.5 AbbVie Recent Development
• 11.9 Amgen
  • 11.9.1 Amgen Company Details
  • 11.9.2 Amgen Business Overview
  • 11.9.3 Amgen Monoclonal Antibody Therapeutics Introduction
  • 11.9.4 Amgen Revenue in Monoclonal Antibody Therapeutics Business (2015-2020)
  • 11.9.5 Amgen Recent Development
• 11.10 Johnson & Johnson
  • 11.10.1 Johnson & Johnson Company Details
  • 11.10.2 Johnson & Johnson Business Overview
  • 11.10.3 Johnson & Johnson Monoclonal Antibody Therapeutics Introduction
  • 11.10.4 Johnson & Johnson Revenue in Monoclonal Antibody Therapeutics Business (2015-2020)
  • 11.10.5 Johnson & Johnson Recent Development
• 11.11 Bristol-Myers Squibb Company
  • 10.11.1 Bristol-Myers Squibb Company Company Details
  • 10.11.2 Bristol-Myers Squibb Company Business Overview
  • 10.11.3 Bristol-Myers Squibb Company Monoclonal Antibody Therapeutics Introduction
  • 10.11.4 Bristol-Myers Squibb Company Revenue in Monoclonal Antibody Therapeutics Business (2015-2020)
  • 10.11.5 Bristol-Myers Squibb Company Recent Development
• 11.12 Biogen
  • 10.12.1 Biogen Company Details
  • 10.12.2 Biogen Business Overview
  • 10.12.3 Biogen Monoclonal Antibody Therapeutics Introduction
  • 10.12.4 Biogen Revenue in Monoclonal Antibody Therapeutics Business (2015-2020)
  • 10.12.5 Biogen Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

• 13.1 Research Methodology
  • 13.1.1 Methodology/Research Approach
  • 13.1.2 Data Source
• 13.2 Disclaimer

Global Monoclonal Antibody Therapeutics Scope and Market Size
Monoclonal Antibody Therapeutics market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Monoclonal Antibody Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

Market segment by Type, the product can be split into
Humanized Antibody
Human Mouse Chimeric Antibody

Market segment by Application, split into
Cancer
Autoimmune Diseases
Infection
Hematological Diseases
Ophthalmological Diseases
Others

Based on regional and country-level analysis, the Monoclonal Antibody Therapeutics market has been segmented as follows:
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of Middle East & Africa

In the competitive analysis section of the report, leading as well as prominent players of the global Monoclonal Antibody Therapeutics market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
The key players covered in this study
Bayer
F. Hoffmann-La Roche
Pfizer
Sanofi
GlaxoSmithKline
Merck
Novartis
AbbVie
Amgen
Johnson & Johnson
Bristol-Myers Squibb Company
Biogen